Results 251 to 260 of about 11,998,196 (407)
Cardiovascular disease in air travellers. [PDF]
Peter Beighton, Peg Richards
openalex +1 more source
AIE‐active tetranuclear Ir(III) complex Ir‐4 as a sonosensitizer/sonocatalyst is formulated into a nanoplatform with an H2S donor. Ir‐4@S‐R NPs achieves combined endogenous NIR chemiluminescence imaging, sonodynamic therapy and release of H2S in situ by a bioorthogonal sonocatalytic reaction in vivo, achieving safe thrombolysis and anti‐inflammatory ...
Zihan Wu+11 more
wiley +1 more source
Role of HIV-encoded proteins in cardiovascular disease. [PDF]
Kovacs L+2 more
europepmc +1 more source
Genetic Aspects of Cardiovascular Diseases in Animals [PDF]
D. K. Detweiler
openalex +1 more source
Nanoscale metal–organic frameworks (MOFs) and nanocellulose composites have significant potential for the multi‐functional remediation of the environment. This review focused on the synthesis strategies (in situ growth, ex situ growth, and other approaches), typical forms (aerogel, hydrogel, beads, and membrane), and applications in the removal of ...
Ye Song+13 more
wiley +1 more source
Cardiovascular disease prevention in sexual minorities, A fellow's voice. [PDF]
Punnanithinont N.
europepmc +1 more source
Angiocardiographic Measurement of the Cardiac Segment of the Inferior Vena Cava in Health and in Cardiovascular Disease [PDF]
Edwin Ettinger, Israel Steinberg
openalex +1 more source
Biomarkers of Cardiovascular Disease [PDF]
Ying Huang+3 more
openaire +3 more sources
An advanced‐fidelity CRISPR nuclease, FnCas9‐AF2, is rationally engineered to discriminate single‐base mismatches with unprecedented level precision. Integrated into the MUTE‐Seq workflow, FnCas9‐AF2 depletes wild‐type cell‐free DNA, thereby exposing rare tumor‐derived mutant DNA (a molecular “needle in a haystack”).
Sunghyeok Ye+20 more
wiley +1 more source